Wells Fargo’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-18,901
| Closed | -$44.4K | – | 6478 |
|
2024
Q1 | $44.4K | Buy |
18,901
+9,522
| +102% | +$22.4K | ﹤0.01% | 4926 |
|
2023
Q4 | $17.7K | Buy |
9,379
+1,850
| +25% | +$3.5K | ﹤0.01% | 5242 |
|
2023
Q3 | $10.3K | Sell |
7,529
-4,055
| -35% | -$5.56K | ﹤0.01% | 5432 |
|
2023
Q2 | $28.1K | Buy |
11,584
+6,186
| +115% | +$15K | ﹤0.01% | 5342 |
|
2023
Q1 | $31.1K | Buy |
+5,398
| New | +$31.1K | ﹤0.01% | 5126 |
|
2022
Q4 | – | Sell |
-923
| Closed | -$13K | – | 7099 |
|
2022
Q3 | $13K | Buy |
923
+630
| +215% | +$8.87K | ﹤0.01% | 5232 |
|
2022
Q2 | $4K | Sell |
293
-1,335
| -82% | -$18.2K | ﹤0.01% | 5760 |
|
2022
Q1 | $33K | Sell |
1,628
-7,058
| -81% | -$143K | ﹤0.01% | 5487 |
|
2021
Q4 | $152K | Sell |
8,686
-4,111
| -32% | -$71.9K | ﹤0.01% | 5039 |
|
2021
Q3 | $100K | Buy |
12,797
+12,796
| +1,279,600% | +$100K | ﹤0.01% | 5085 |
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6495 |
|
2021
Q1 | $0 | Sell |
1
-9,288
| -100% | – | ﹤0.01% | 6467 |
|
2020
Q4 | $130K | Buy |
9,289
+9,288
| +928,800% | +$130K | ﹤0.01% | 5105 |
|
2020
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5909 |
|
2020
Q2 | – | Sell |
-5,260
| Closed | -$38K | – | 5836 |
|
2020
Q1 | $38K | Buy |
5,260
+4,145
| +372% | +$29.9K | ﹤0.01% | 5194 |
|
2019
Q4 | $12K | Sell |
1,115
-398
| -26% | -$4.28K | ﹤0.01% | 5535 |
|
2019
Q3 | $94K | Buy |
1,513
+1,132
| +297% | +$70.3K | ﹤0.01% | 5109 |
|
2019
Q2 | $27K | Sell |
381
-109
| -22% | -$7.72K | ﹤0.01% | 5384 |
|
2019
Q1 | $23K | Hold |
490
| – | – | ﹤0.01% | 5392 |
|
2018
Q4 | $30K | Buy |
490
+315
| +180% | +$19.3K | ﹤0.01% | 5348 |
|
2018
Q3 | $19K | Buy |
175
+60
| +52% | +$6.51K | ﹤0.01% | 5484 |
|
2018
Q2 | $7K | Sell |
115
-34
| -23% | -$2.07K | ﹤0.01% | 5656 |
|
2018
Q1 | $10K | Buy |
+149
| New | +$10K | ﹤0.01% | 5560 |
|